Abbott Laboratories ABT is set to release its quarterly earnings results on Wednesday prior to the opening bell. Heading into the report, Wall Street analysts have consensus earnings estimates of $1.28 per share. The low estimate on the Street is $1.26 with a high estimate of $1.31. In the year ago period, Abbott reported EPS of $1.18.
Revenues are expected to be $9.93 billion which implies 1.20 percent sales growth versus last year's corresponding quarter. The low revenue estimate is $9.75 billion with a high estimate of $10.14 billion.
Over the last three months, EPS estimates for Abbot have risen by a penny. During this time, the stock has surged nearly 10 percent. Year-to-date, ABT has climbed almost 28 percent. On Tuesday, ahead of Wednesday's key report the stock was trading down 0.17 percent to $71.93 into the closing bell.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in